☆ 4.2 Article

Safety of subcutaneous and sublingual immunotherapy with allergoids in children: a real-life pharmacovigilance study

IMMUNOTHERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Allergy

Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study

Marco Contoli et al.

Summary: This study assessed the real-world, long-term effectiveness and safety of allergy immunotherapy (AIT) and found that AIT showed positive effects in reducing prescriptions for allergic rhinitis. Persistence to AIT and the use of SQ grass sublingual immunotherapy (SLIT) tablet demonstrated sustained and significant reductions in prescriptions, while tree-specific AIT showed smaller reductions. The study emphasizes the importance of using evidence-based AIT products for tree pollen allergies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Allergy

Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce

Julijana Asllani et al.

Summary: This study investigated the safety of allergen immunotherapy (AIT) in children with respiratory allergies. The results showed that AIT is safe and well tolerated in children and adolescents with respiratory allergies in real-life clinical practice, with few and mild adverse events.

CLINICAL AND TRANSLATIONAL ALLERGY (2023)

Add to Collection

Review Pediatrics

Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review

Chen Zheng et al.

Summary: This study evaluated the efficacy and safety of subcutaneous immunotherapy (SCIT) in asthmatic children with allergy to house dust mite. The results showed that SCIT can reduce short-term asthma symptoms and medication scores, but with an increased risk of adverse reactions. Further studies are needed to evaluate the long-term efficacy of SCIT and its effectiveness in specific populations.

FRONTIERS IN PEDIATRICS (2023)

Add to Collection

Article Immunology

Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan

Yoshitaka Okamoto et al.

Summary: A Japanese study investigated the safety and effectiveness of the 300 index of reactivity house dust mite (HDM) sublingual tablet during its use for up to 4 years. The results showed that the long-term use of this tablet is safe and effective, with a significant decrease in severe allergic rhinitis symptoms and sustained improvement after discontinuation of the treatment.

IMMUNOTHERAPY (2023)

Add to Collection

Article Immunology

Modification of allergen subcutaneous immunotherapy safety precautions and systemic allergic reaction rate reduction

Keren Mahlab-Guri et al.

Summary: Despite the potential life-threatening nature of medical team mistakes during subcutaneous immunotherapy, they are rarely discussed. A survey study estimates that dosing errors account for 25% of systemic reactions during immunotherapy. To minimize these errors, the researchers modified their safety precautions by adding a second check of the injected allergen/s by another nurse/physician. They then compared the rates of systemic allergic reactions before and after the change.

IMMUNOTHERAPY (2023)

Add to Collection

Article Medicine, General & Internal

Subcutaneous Immunotherapy (SCIT) with the New Polymerized Molecular Allergoid Alt a1: A Pilot Study in Children with Allergic Rhinitis Sensitized to Alternaria Alternata

Giulia Brindisi et al.

Journal of Clinical Medicine (2023)

Add to Collection

Article Medicine, General & Internal

Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice-An Open, Prospective, Non-Interventional Study

Christoph Owenier et al.

Summary: This non-interventional study investigated the tolerability and safety of two sublingual tree pollen extracts. The study found that both products were well tolerated and demonstrated a good safety profile.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Immunology

Allergen immunotherapy: past, present and future

Stephen R. Durham et al.

Summary: Allergen immunotherapy is a therapeutic vaccination for established IgE-mediated hypersensitivity. It involves repeated injection of allergen extracts, leading to allergen-specific tolerance. Sublingual administration has emerged as an effective alternative. The mechanisms of immunotherapy-induced tolerance involve reduction of allergen-specific T(H)2 cells, induction of regulatory T and B cells, and production of blocking antibodies. Novel strategies are being explored to achieve safer and more effective long-term tolerance.

NATURE REVIEWS IMMUNOLOGY (2023)

Add to Collection

Article Allergy

Safety of allergen-specific immunotherapy in children

Maria De Filippo et al.

Summary: Allergic respiratory diseases have become increasingly prevalent worldwide and allergen-specific immunotherapy is the only curative treatment. This paper summarizes recent evidence on local and systemic reactions related to subcutaneous and sublingual immunotherapy in children.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2022)

Add to Collection

Review Cell Biology

Allergen Immunotherapy: Current and Future Trends

Gandhi F. Pavon-Romero et al.

Summary: Allergen immunotherapy (AIT) is an effective treatment for allergic rhinitis, preventing progression to asthma and reducing medication use. AIT works by inducing immunological tolerance and increasing specific levels and cell counts. Recent advancements in AIT research have focused on modifying allergens to improve treatment outcomes and minimize adverse reactions.

CELLS (2022)

Add to Collection

Review Allergy

Allergen Immunotherapy in Young Children

Venusa Phomakay et al.

Summary: Allergen immunotherapy (AIT) is a safe and effective treatment strategy for allergic diseases in children, providing disease-modifying and preventative effects not shared by other treatment options. Its benefits include improved symptoms and quality of life, reduced medication use, and prevention of new allergen sensitizations and progression to asthma.

CURRENT ALLERGY AND ASTHMA REPORTS (2022)

Add to Collection

Article Allergy

Allergen immunotherapy and shared decision-making

Russell A. Settipane et al.

Summary: Clinical decision-making in allergic rhinoconjunctivitis management is complex, and shared decision-making with aids and tools can facilitate the involvement of practitioners and patients in the decision-making process.

ALLERGY AND ASTHMA PROCEEDINGS (2022)

Add to Collection

Article Immunology

Safety of subcutaneous immunotherapy with carbamylated allergoids based on data from a pharmacovigilance database

Frati Franco et al.

Summary: This study assessed the safety of subcutaneous immunotherapy with the monomeric allergoid Lais-in, and the results showed that this treatment can prevent serious reactions.

IMMUNOTHERAPY (2022)

Add to Collection

Article Allergy

Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis

Wenlong Liu et al.

Summary: The study compared the efficacy, safety, and compliance of SCIT and SLIT in children with allergic rhinitis. Results indicated that SCIT was more effective than SLIT to a certain degree but had higher occurrence of adverse events. Individuals can choose the appropriate AIT route based on their specific conditions.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2021)

Add to Collection

Review Allergy

Mechanisms of Allergen Immunotherapy in Allergic Rhinitis

Gabija Drazdauskaite et al.

Summary: Allergic rhinitis is a chronic inflammatory disease of the nasal mucosa triggered by allergens, with symptoms such as sneezing, rhinorrhea, nasal itching, nasal congestion, and allergic conjunctivitis. It impacts a quarter of the populations in the USA and Europe.

CURRENT ALLERGY AND ASTHMA REPORTS (2021)

Add to Collection

Article Allergy

Accelerated Dose Escalation with 3 Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of 6 Grasses Is Safe for Children and Adolescents with Moderate to Severe Allergic Rhinitis

Xenia Bovermann et al.

Summary: The study found that an accelerated dose escalation schedule of allergen-specific immunotherapy with grass pollen allergoid was safe and well-tolerated in children and adolescents with moderate to severe seasonal rhinoconjunctivitis. Treatment-emergent adverse events related to AIT were reported in both children and adolescents, with systemic allergic reactions occurring in about 5% of patients.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2021)

Add to Collection

Article Allergy

Real-world safety and effectiveness evidence of a microcrystalline tyrosine-associated mite allergoid in children and adolescents with allergic rhinitis

Anna Sala-Cunill et al.

Summary: This study evaluated the safety and effectiveness of AIT with an MCT-associated mite allergoid in children and adolescents with AR. The results showed that AIT treatment significantly reduced unscheduled visits and emergency room admissions, improved symptoms, decreased medication use, and enhanced patients' disease perception in a real-world setting.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2021)

Add to Collection

Review Allergy

A meta-analysis on allergen-specific immunotherapy using MCT(R) (MicroCrystalline Tyrosine)-adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis

Sven Becker et al.

Summary: This meta-analysis evaluated the efficacy and safety of Glutaraldehyde-modified and MCT(R)-adsorbed allergoids (MATA), showing significant reduction in allergic symptoms and medication use with good safety profile. Especially for children and asthmatic patients, MATA can be considered safe and effective.

CLINICAL AND TRANSLATIONAL ALLERGY (2021)

Add to Collection

Article Immunology

The safety of carbamylated monomeric allergoids for sublingual immunotherapy. Data from a pharmacovigilance study

Enrico Compalati et al.

IMMUNOTHERAPY (2020)

Add to Collection

Article Allergy

Oral immunotherapy in pediatrics

Stefania Arasi et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)

Add to Collection

Review Allergy

The role of allergoids in allergen immunotherapy: from injective to sublingual route

E. Compalati et al.

EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Fast up-dosing with a birch allergoid is safe and well tolerated in allergic rhinitis patients with or without asthma

Stefan Zielen et al.

IMMUNOTHERAPY (2019)

Add to Collection

Article Immunology

Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life

Marco Caminati et al.

IMMUNOTHERAPY (2019)

Add to Collection

Review Allergy

Contraindications to immunotherapy: a global approach

C. Pitsios et al.

CLINICAL AND TRANSLATIONAL ALLERGY (2019)

Add to Collection

Article Pediatrics

Diagnosis and Management of Allergic Rhinitis in Children

Timothy Brown

PEDIATRIC ANNALS (2019)

Add to Collection

Article Allergy

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy

M. Worm et al.

ALLERGY (2018)

Add to Collection

Editorial Material Allergy

Safety of an Accelerated Build-up Phase With Pollen Allergoids: A Retrospective Study

C. Caruso et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection

Article Allergy

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

G. Roberts et al.

ALLERGY (2018)

Add to Collection

Article Allergy

SCIT with a high-dose house dust mite allergoid is well tolerated. Safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups

Ludger Klimek et al.

ALLERGO JOURNAL (2018)

Add to Collection

Review Pharmacology & Pharmacy

Allergoids for Allergy Treatment

Jeronimo Carnes et al.

RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2018)

Add to Collection

Article Allergy

European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment

M. A. Calderon et al.

ALLERGY (2017)

Add to Collection

Article Allergy

The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment

Pablo Rodriguez del Rio et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2017)

Add to Collection

Review Pediatrics

Subcutaneous and Sublingual immunotherapy in Allergic Asthma in Children

Sophia Tsabouri et al.

FRONTIERS IN PEDIATRICS (2017)

Add to Collection

Review Pediatrics

Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report

Giovanni Battista Pajno et al.

ITALIAN JOURNAL OF PEDIATRICS (2017)

Add to Collection

Review Otorhinolaryngology

Epidemiology of asthma

Patricia A. Loftus et al.

CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY (2016)

Add to Collection

Article Allergy

Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age

Mario Morais-Almeida et al.

ASIA PACIFIC ALLERGY (2016)

Add to Collection

Review Pharmacology & Pharmacy

Safety of sublingual immunotherapy in children

Franco Frati et al.

EXPERT OPINION ON DRUG SAFETY (2014)

Add to Collection

Article Allergy

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System

Linda Cox et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Add to Collection

Article Public, Environmental & Occupational Health

Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA)

EG Brown

DRUG SAFETY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.